Albany International (AIN) Q3 2026 Earnings Call Transcript

Albany International reported record Q3 revenue of $349.5 million, up 34% year over year, and adjusted diluted EPS of $1.68, above its previously revised range. Results included a $12 million revenue and $44 million adjusted EBITDA benefit from the CH-53K contract renegotiation; adjusted EBITDA was $100.1 million, including a $44 million reach-forward loss reversal, while AEC's underlying EBITDA margin was 12.5%. Management forecast Q4 revenue of $325 million to $335 million and adjusted EPS of $0.65 to $0.75 per diluted share, targeting mid-teens AEC margins by the end of 2027.

Analysis

The key distinction is between a resolved legacy liability and a proven growth engine. Q3 profitability is not a clean run rate: the CH-53K accounting benefit, tariff refunds and other discrete items flatter reported earnings and cash conversion. Management’s 12.5% underlying AEC margin is the more useful base; the mid-teens target by exit 2027 requires pricing, mix and execution to offset ramp costs. The upcoming Investor Day is the next test of whether missile/CMC opportunities translate into funded, timed production rather than a promising pipeline. Government support reduces Albany’s upfront burden, but does not itself establish customer orders or attractive returns on incremental capacity. Over 6–18 months, faster missile demand could improve AEC utilization and diversify growth; conversely, qualification delays or customer schedule changes could leave new capacity underused. Machine Clothing remains a cash-generative counterweight, but consolidation and secular weakness in publication grades limit its ability to offset AEC execution risk. Near term, the large gap between Q3 earnings and Q4 guidance creates a risk that investors anchor on exceptional Q3 margins. The contrarian opportunity is that the market may either over-credit the one-time settlement or under-credit a genuine reduction in legacy risk; December targets and subsequent underlying margins should resolve that debate.

Key Decisions for Investors

• Do not annualize Q3 adjusted EBITDA or free cash flow. For AIN, use management’s 12.5% underlying AEC margin as the starting point and treat the CH-53K benefit and cash timing items as non-recurring until filings and subsequent quarters confirm otherwise.
• Watch AIN through the December Investor Day rather than chase the headline quarter. Consider a staged long only if management supplies credible program timing, capacity investment and cash-conversion milestones; the potential upside is improving AEC margins as production ramps, while the main downside is a valuation reset if guidance or delivery slips.
• Track Q4 revenue/EPS delivery, AEC underlying margin, machine-clothing volume recovery, and any customer-funded versus Albany-funded CMC capacity. Falsify the improving thesis if AEC margins fail to progress from the stated base, missile ramps move out materially, or machine-clothing weakness deepens.
• No direct LMT trade is indicated: the disclosed relationship does not establish a material earnings sensitivity for Lockheed Martin, and the transcript provides no basis to size a relative-value position.